Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$153M |
| 2 |
GE Vernova
GEV
|
+$129M |
| 3 |
Ferrovial N.V. Ordinary Shares
FER
|
+$61.6M |
| 4 |
Solventum
SOLV
|
+$26.3M |
| 5 |
Strategy Inc
MSTR
|
+$25.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$184M |
| 2 |
GE Aerospace
GE
|
+$135M |
| 3 |
Apple
AAPL
|
+$104M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
Meta Platforms (Facebook)
META
|
+$77.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.83% |
| 2 | Healthcare | 12.16% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Communication Services | 9.35% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHCT
2051
Community Healthcare Trust
CHCT
$433M
| $1.27M | ﹤0.01% |
54,500
+3,400
| +7% | +$82.6K |
|
2052
Vaalco Energy
EGY
$592M
| $1.27M | ﹤0.01% |
203,200
-6,700
| -3% | -$43.2K |
|
|
INN
2053
Summit Hotel Properties
INN
$656M
| $1.27M | ﹤0.01% |
212,000
| – | – |
|
|
ATRI
2054
DELISTED
Atrion Corp
ATRI
| $1.27M | ﹤0.01% |
2,802
| – | – |
|
2055
Astec Industries
ASTE
$975M
| $1.26M | ﹤0.01% |
42,600
| – | – |
|
2056
Nabors Industries
NBR
$1.35B
| $1.26M | ﹤0.01% |
17,700
-800
| -4% | -$59.6K |
|
2057
Ethan Allen Interiors
ETD
$583M
| $1.26M | ﹤0.01% |
45,100
| – | – |
|
2058
Forestar Group
FOR
$1.51B
| $1.26M | ﹤0.01% |
39,317
| – | – |
|
2059
B&G Foods
BGS
$299M
| $1.25M | ﹤0.01% |
155,200
| – | – |
|
|
HSII
2060
DELISTED
Heidrick & Struggles
HSII
| $1.25M | ﹤0.01% |
39,500
| – | – |
|
2061
Heritage Financial
HFWA
$1.23B
| $1.25M | ﹤0.01% |
69,068
| – | – |
|
2062
Byline Bancorp
BY
$1.78B
| $1.24M | ﹤0.01% |
52,400
-7,900
| -13% | -$176K |
|
2063
CG Oncology
CGON
$6.62B
| $1.24M | ﹤0.01% |
+39,400
| New | +$1.37M |
|
2064
DXP Enterprises
DXPE
$3B
| $1.24M | ﹤0.01% |
27,100
| – | – |
|
|
DEC
2065
Diversified Energy Company
DEC
$1B
| $1.24M | ﹤0.01% |
93,516
-1,848
| -2% | -$25.7K |
|
|
CFB
2066
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $1.23M | ﹤0.01% |
87,400
| – | – |
|
2067
UWM Holdings
UWMC
$2.61B
| $1.22M | ﹤0.01% |
176,600
+2,300
| +1% | +$15.8K |
|
2068
Cytek Biosciences
CTKB
$636M
| $1.22M | ﹤0.01% |
218,800
+4,800
| +2% | +$28.8K |
|
2069
Gogo Inc
GOGO
$377M
| $1.22M | ﹤0.01% |
126,800
| – | – |
|
2070
Hain Celestial
HAIN
$53.9M
| $1.22M | ﹤0.01% |
176,314
| – | – |
|
2071
GoodRx Holdings
GDRX
$1.27B
| $1.21M | ﹤0.01% |
155,000
| – | – |
|
|
PETQ
2072
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $1.21M | ﹤0.01% |
54,700
| – | – |
|
2073
AdvanSix
ASIX
$446M
| $1.21M | ﹤0.01% |
52,600
-1,100
| -2% | -$27.4K |
|
2074
NextDecade
NEXT
$1.8B
| $1.21M | ﹤0.01% |
151,800
-25,400
| -14% | -$175K |
|
2075
Viridian Therapeutics
VRDN
$2.49B
| $1.2M | ﹤0.01% |
92,600
+9,700
| +12% | +$134K |
|
Similar funds
Swiss National Bank's Q2 2024 Portfolio in Review
As of Q2 2024, Swiss National Bank held 2,546 positions worth $146B, up 2% from $143B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Swiss National Bank's Q2 2024 filing shows 41 new, 569 increased, 1,097 reduced and 88 closed positions. Its largest new stake was GE Vernova: 811,465 shares worth $139M. The largest sale was Pioneer Natural Resource Co., an estimated $184M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2024 buy was GE Vernova: 811,465 shares worth $139M.
- Swiss National Bank added most to ExxonMobil in Q2 2024, an estimated $153M increase.
- Swiss National Bank's biggest Q2 2024 reduction was GE Aerospace, cutting an estimated $135M.
- Swiss National Bank fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $184M.
- Swiss National Bank's ten largest holdings make up 33% of its $146B portfolio in Q2 2024.
- Swiss National Bank opened 41 new positions and closed 88 in Q2 2024.
- Swiss National Bank's portfolio value rose 2% quarter-over-quarter to $146B.
Based on Swiss National Bank's 13F filing for Q2 2024, filed 8 Aug 2024.